highaltitud
pulmonari
edema
hape
specif
diseas
high
altitud
high
incid
often
seriou
rapid
progress
also
lifethreaten
treatment
start
time
manner
mani
studi
shown
hape
major
diseas
often
affect
nonacclimat
healthi
individu
ascend
high
altitud
therefor
earli
diagnosi
hape
essenti
initi
earli
treatment
hape
maintain
safeti
peopl
ascent
high
altitud
although
intern
chines
criteria
establish
hape
earli
detect
diagnosi
difficult
except
presenc
typic
pulmonari
edema
follow
magnitud
earthquak
struck
yushu
yushu
tibetan
autonom
prefectur
qinghai
provinc
china
april
approxim
rescuer
assembl
region
region
lie
altitud
rang
averag
altitud
although
incid
hape
sudden
influx
nonacclimat
rescuer
region
meant
hape
one
common
lifethreaten
diseas
time
even
consid
effect
earthquak
caus
death
peopl
miss
injur
hape
also
induc
psycholog
disord
affect
individu
therefor
essenti
highlight
earli
diagnosi
onsit
treatment
hape
support
nation
scienc
technolog
program
conduct
extens
rang
studi
hape
intend
find
effect
method
earli
diagnosi
clinic
treatment
hape
thu
improv
health
safeti
individu
rapidli
ascend
high
altitud
gener
difficult
physician
diagnos
typic
hape
base
medic
histori
symptom
sign
includ
white
yellow
pink
frothi
sputum
moist
rale
pulmonari
auscult
floccul
shadow
chest
xray
howev
atyp
hape
much
difficult
diagnos
patient
usual
develop
atyp
hape
altitud
may
occur
sever
day
longer
ascend
altitud
symptom
differ
typic
hape
less
sputum
absenc
sputum
nonspecif
find
chest
xray
base
previou
studi
develop
hape
classifi
two
stage
onset
presenc
typic
symptom
earli
stage
character
interstiti
pulmonari
edema
late
stage
character
alveolar
pulmonari
edema
patient
interstiti
pulmonari
edema
usual
exhibit
seriou
dyspnea
typic
sign
pink
frothi
sputum
extens
moist
rale
wheezi
phlegm
thu
patient
suscept
misdiagnosi
delay
treatment
li
et
al
investig
characterist
hape
patient
examin
clinic
symptom
sign
perform
routin
blood
test
electrocardiographi
color
doppler
echocardiographi
chest
xray
comput
tomographi
ct
patient
found
hape
patient
exhibit
signific
differ
paramet
compar
nonhap
patient
symptom
sign
obviou
hape
patient
nonhap
patient
addit
studi
reveal
oxygen
treatment
effect
hape
form
lung
injuri
therefor
research
propos
tent
oxygen
treatment
use
earli
diagnosi
hape
nevertheless
import
examin
earli
diagnosi
hape
chest
xray
ct
chest
xray
hape
often
present
decreas
pulmonari
transmitt
increas
obscur
lung
mark
ground
glasslik
chang
lung
patchi
shadow
ct
scan
increas
enlarg
lung
mark
ground
glasslik
chang
lung
nodulelik
shadow
scatter
isol
alveolar
edema
termin
bronchiol
slim
reticul
shadow
observ
accord
clinic
symptom
sign
find
blood
routin
test
electrocardiographi
color
doppler
echocardiographi
chest
xray
ct
follow
criteria
hape
develop
diagnosi
hape
criteria
must
met
find
togeth
andor
use
confirm
hape
use
criteria
sever
diseas
determin
critic
individu
therapi
earli
diagnosi
earli
treatment
hape
control
earli
stage
symptom
markedli
improv
dyspnea
cough
white
foami
sputum
may
occur
intermedi
manual
labor
lung
auscult
show
local
moist
rale
unilater
lung
respiratori
rate
often
breathsmin
heart
rate
beatsmin
arrhythmia
chest
xray
show
area
floccul
shadow
occupi
lung
shadow
confin
right
lower
lobe
spotti
patchi
ct
scan
reveal
increas
enlarg
lung
mark
routin
blood
test
normal
dyspnea
chest
pain
chest
tight
cough
larg
amount
white
foami
sputum
occur
mild
manual
labor
extens
moist
rale
note
bilater
lower
lung
unilater
lung
lung
auscult
respiratori
rate
breathsmin
heart
rate
beatsmin
accompani
arrhythmia
chest
xray
show
patchi
floccul
shadow
cover
lung
ct
scan
show
ground
glasslik
chang
nodulelik
shadow
white
blood
cell
count
neutrophil
count
slightli
increas
patient
lie
supin
prone
posit
may
pale
complexion
cold
sweat
forehead
seriou
dyspnea
heavi
cough
larg
amount
white
pink
foami
sputum
rale
small
intermedi
larg
bubbl
extens
bilater
lung
accompani
sound
boil
water
respiratori
rate
breathsmin
heart
rate
beatsmin
accompani
arrhythmia
chest
xray
reveal
asymmetr
cloudi
shadow
cover
bilater
lung
ct
scan
indic
scatter
isol
alveolar
edema
termin
bronchiol
white
blood
cell
count
symptom
sign
seriou
sever
hape
patient
high
risk
die
pale
complexion
weak
breath
larg
amount
foam
discharg
nose
mouth
gurgl
sound
audibl
bilater
lung
heart
sound
weak
blood
pressur
decreas
patient
also
like
highaltitud
cerebr
edema
heart
failur
secondari
pulmonari
infect
like
chest
xray
reveal
floccul
shadow
unilater
bilater
lung
enlarg
heart
pulmonari
arteri
particularli
clear
ct
scan
show
diffus
alveolar
edema
unilater
bilater
lung
number
white
blood
cell
term
pharmacotherapi
consensu
type
drug
dose
administr
rout
hape
thu
imper
develop
guidelin
standard
optim
treatment
hape
base
experi
sever
mountain
sick
treatment
center
efficaci
current
avail
drug
strategi
combin
recent
advanc
treatment
hape
research
group
propos
four
regimen
earli
diagnosi
treatment
hape
conduct
prospect
random
control
studi
investig
efficaci
total
patient
hape
divid
four
group
treat
follow
patient
group
receiv
oxygen
inhal
dexamethason
aminophyllin
patient
group
bc
treat
group
addit
diuresi
furosemid
group
b
blood
pressurelow
nifedipin
group
c
larginin
group
efficaci
safeti
therapeut
regimen
compar
treatment
show
greatest
therapeut
efficaci
subsequ
use
prepar
guidelin
treatment
hape
overal
four
regimen
effect
treatment
hape
howev
term
time
resolut
symptom
sign
time
resolut
chest
xray
find
durat
hospit
regimen
b
superior
regimen
interestingli
mark
differ
regimen
c
furthermor
differ
incid
advers
effect
regimen
b
liver
kidney
function
four
regimen
find
suggest
regimen
compos
oxygen
inhal
dexamethason
aminophyllin
furosemid
effect
well
toler
simpl
follow
thu
offer
basic
standard
regimen
treatment
hape
regimen
select
time
initi
individu
treatment
key
factor
contribut
toward
therapeut
efficaci
experi
onsit
treatment
patient
hape
shown
onsit
individu
treatment
feasibl
without
increas
risk
death
follow
yushu
earthquak
efficaci
regimen
confirm
prognosi
onsit
treatment
significantli
better
blind
evacu
usual
result
poor
outcom
bed
rest
intermitt
oxygen
inhal
subcutan
oxygen
treatment
oral
aminophyllin
mg
prednison
mg
furosemid
mg
atropin
anisodamin
mg
twice
daili
treatment
specif
symptom
recommend
absolut
bed
rest
continu
oxygen
inhal
subcutan
oxygen
treatment
necessari
drug
mainli
administ
intramuscularli
accompani
oral
intraven
medic
aminophyllin
mg
prednison
mg
furosemid
mg
atropin
anisodamin
mg
three
four
time
daili
treatment
specif
symptom
recommend
absolut
bed
rest
prefer
semirecumb
posit
continu
highflow
oxygen
inhal
defoam
agent
humidifi
bottl
necessari
drug
mainli
administ
intraven
intramuscularli
atropin
h
anisodamin
h
dexamethason
h
furosemid
h
gentamicin
h
dexamethason
mg
furosemid
mg
atropin
anisodamin
mg
gentamicin
iu
glucos
solut
ml
three
time
daili
recommend
symptomat
treatment
may
includ
intramuscular
morphin
mg
patient
dysphoria
intramuscular
cedilanid
mg
patient
heart
failur
vitamin
c
atp
solut
coenzym
cytochrom
c
deem
necessari
onsit
treatment
prefer
follow
escal
therapi
evacu
patient
condit
stabil
procedur
treatment
extrem
sever
hape
similar
sever
hape
except
treatment
complic
patient
cerebr
edema
dose
dexamethason
diuret
increas
airway
mainten
necessari
hyperbar
oxygen
treatment
oxygen
inhal
ventil
also
recommend
hypothermia
benefici
brain
patient
seriou
heart
failur
half
twothird
recommend
dose
digitali
administ
combin
appropri
dose
sed
daili
dose
glucos
g
maintain
low
energi
consumpt
promot
osmot
diuresi
treatment
escal
evacu
patient
condit
stabil
follow
factor
particularli
import
evacu
mode
transport
patient
transport
vehicl
provid
rapid
steadi
evacu
transport
option
includ
helicopt
motor
truck
heavyduti
medic
car
miniambul
vehicl
speed
care
control
particularli
undul
condit
ensur
patient
remain
horizont
posit
excess
movement
avoid
accompani
personnel
patient
ideal
accompani
one
nurs
one
physician
least
one
medic
staff
provid
effect
onsit
treatment
personnel
continu
monitor
record
patient
vital
sign
perform
treatment
deem
necessari
patient
posit
patient
kept
semirecumb
posit
airway
mainten
essenti
howev
supin
posit
recommend
patient
coma
head
vibrat
bump
avoid
prevent
cerebr
hernia
deceas
patient
time
death
patient
symptom
sign
death
record
bodi
remain
stabl
posit
patient
suspect
heart
failur
treatment
digitali
eg
cedilanid
digoxin
recommend
improv
myocardi
contractil
patient
low
blood
pressur
dextran
hydroxyethyl
starch
recommend
blood
volum
expans
patient
secondari
infect
penicillin
antibiot
administ
patient
dysphoria
sed
given
accord
diseas
state
summari
patient
mild
moder
hape
receiv
basic
treatment
plu
supplementari
treatment
requir
patient
sever
extrem
sever
hape
also
receiv
treatment
symptom
basic
treatment
consist
bed
rest
oxygen
inhal
intraven
administr
aminophyllin
dexamethason
furosemid
supplementari
treatment
includ
antibiot
vitamin
c
cytochrom
c
exampl
physic
activ
may
lead
contract
pulmonari
vessel
result
increas
pulmonari
arteri
pressur
decreas
arteri
partial
pressur
oxygen
therefor
absolut
bed
rest
reduc
muscular
activ
contract
blood
vessel
thu
provid
stabl
pulmonari
arteri
pressur
studi
bed
rest
alon
use
treatment
mild
hape
oxygen
inhal
decreas
pulmonari
arteri
pressur
evid
show
inhal
oxygen
significantli
decreas
increas
pulmonari
arteri
pressur
accompani
improv
symptom
addit
oxygen
inhal
increas
arteri
oxygen
satur
improv
tissu
oxygen
suppli
thu
allevi
hypoxia
patient
sever
hape
hyperbar
oxygen
prefer
research
propos
mechan
ventil
patient
respiratori
distress
hyperbar
oxygen
treatment
increas
oxygen
concentr
subsequ
alveolar
arteri
partial
pressur
oxygen
also
increas
pulmonari
ventil
alveolar
pressur
inhibit
fluid
exud
oxygen
inhal
also
rectifi
respiratori
alkalosi
prevent
transport
peripher
blood
lung
experiment
studi
shown
hypoxia
result
reduc
nitric
oxid
level
principl
caus
pulmonari
vasoconstrict
inhal
nitric
oxid
reduc
hypox
pulmonari
hypertens
improv
patient
ventil
perfus
ratio
improv
hypoxemia
improv
hape
patient
sign
symptom
well
decreas
hospit
time
advers
effect
accordingli
suggest
nitric
oxid
inhal
consid
treatment
hape
administ
via
nasal
cathet
dose
ppm
flow
rate
lmin
min
normal
air
oxygen
aminophyllin
classic
bronchodil
long
use
treatment
hape
aminophyllin
dilat
bronchu
decreas
hypox
pulmonari
hypertens
enhanc
diaphragm
function
suppress
lipid
peroxid
hypoxiainduc
pulmonari
vascular
inflamm
enhanc
cardiac
function
diuresi
clear
bronchial
mucu
subsequ
resolv
moist
rale
unlik
bronchodil
aminophyllin
dilat
bronchu
vascular
smooth
muscl
henc
prefer
bronchodil
treatment
hape
hospit
use
anisodamin
instead
aminophyllin
treatment
hape
anisodamin
improv
pulmonari
vascular
spasm
decreas
pulmonari
vascular
resist
hypox
pulmonari
hypertens
improv
pulmonari
microcircul
maintain
smooth
pulmonari
blood
flow
result
anisodamin
inhibit
intravascular
coagul
thu
reduc
risk
pulmonari
embol
nifedipin
calcium
channel
blocker
inhibit
releas
catecholamin
sympathet
nerv
end
therefor
effect
vasodil
reduc
hypox
pulmonari
hypertens
increas
arteri
oxygen
tension
improv
symptom
sign
hape
lower
right
atrial
pressur
increas
cardiac
output
therefor
nifedipin
target
mani
effect
hape
hypoxia
lead
redistribut
system
blood
abrupt
increas
pulmonari
blood
volum
furosemid
chlorothiazid
promot
diuresi
dehydr
also
increas
renal
blood
flow
reduc
left
ventricular
fill
pressur
thu
blood
lung
transport
peripheri
improv
pulmonari
congest
addit
oral
acetazolamid
play
signific
role
treatment
hape
increas
urin
output
patient
hape
fluid
retent
acetazolamid
carbon
anhydras
inhibitor
inhibit
carbon
anhydras
activ
brain
kidney
blood
kidney
acetazolamid
reduc
format
hydrogen
bicarbon
ion
inhibit
sodium
bicarbon
reabsorpt
increas
urin
output
thu
reduc
sodium
water
retent
brain
acetazolamid
inhibit
brain
choroid
plexu
carbon
anhydras
activ
reduc
cerebrospin
fluid
product
rate
henc
reduc
intracrani
pressur
dexamethason
analog
adrenocort
hormon
improv
function
capillari
endotheli
cell
alveolar
epitheli
cell
decreas
pulmonari
capillari
permeabl
protect
alveolar
epitheli
type
ii
cell
promot
secret
pulmonari
surfact
increas
renal
blood
flow
decreas
secret
antidiuret
hormon
thu
dexamethason
key
drug
treatment
hape
respiratori
ga
exchang
disord
may
predict
seriou
hypoxemia
even
acut
mountain
sick
individu
rapidli
ascend
high
altitud
thu
monitor
arteri
oxygen
satur
use
predict
hape
studi
shown
patient
seriou
hypoxemia
develop
hape
accordingli
roach
et
al
specul
noninvas
measur
simpl
conveni
way
predict
onset
hape
similarli
burtscher
et
al
suggest
measur
could
use
predict
onset
acut
mountain
sick
prospect
cohort
studi
shen
et
al
found
signific
individu
differ
chang
oxygen
satur
increas
altitud
found
decreas
low
altitud
suscept
hape
increas
markedli
particip
develop
hape
thu
specul
decreas
offer
biomark
predict
suscept
hape
zhang
et
al
use
submaxim
bench
step
directli
calcul
maxim
oxygen
uptak
appli
predict
hape
conduct
studi
soldier
ascend
high
altitud
found
soldier
lmin
sea
level
less
like
develop
hape
lmin
wang
zhou
measur
fvc
bodi
surfac
area
thorac
volum
effort
predict
hape
individu
ascend
high
altitud
found
fvcbodi
surfac
area
fvcthorac
volum
lungbodi
index
lungthorax
index
associ
increas
risk
hape
geng
et
al
investig
diffus
carbon
monoxid
co
lung
subject
rapidli
ascend
found
co
diffus
correl
develop
acut
mountain
sick
patient
hape
diffus
capac
co
dlco
increas
increas
altitud
amplitud
increas
greater
subject
without
hape
thu
specul
insuffici
dlco
caus
acut
mountain
sick
dlco
object
paramet
predict
adapt
high
altitud
occurr
hape
huang
et
al
measur
urin
volum
within
h
particip
administ
ml
water
sea
level
effort
predict
hape
found
urin
volum
subject
develop
acut
mountain
respons
significantli
lower
control
group
addit
urin
volum
h
hydrat
total
urin
volum
within
h
hydrat
neg
associ
am
conclud
greater
urin
volum
within
h
hydrat
sea
level
associ
milder
symptom
acut
mountain
sick
ascend
high
altitud
therefor
urin
volum
hydrat
might
marker
acut
mountain
sick
zhou
et
al
measur
ph
blood
individu
ascend
high
altitud
addit
studi
blood
ph
significantli
associ
suscept
hape
signific
differ
blood
ph
valu
subject
develop
hape
without
hape
found
intens
physic
labor
follow
rapid
ascent
likelihood
develop
acut
mountain
sick
significantli
greater
among
individu
blood
ph
among
blood
ph
howev
found
signific
differ
two
group
subject
thu
conclud
blood
ph
could
use
predictor
hape
zhou
et
al
investig
ventilatori
function
newli
recruit
soldier
sea
level
soldier
transfer
airplan
two
three
day
ascend
high
altitud
investig
score
symptom
acut
mountain
sick
evalu
relationship
ventilatori
function
symptom
score
found
fvc
peak
expiratori
flow
forc
expiratori
volum
second
soldier
hape
significantli
lower
soldier
without
hape
thu
specul
ventilatori
function
sea
level
could
use
screen
subject
suscept
hape
wu
li
investig
whether
cardiopulmonari
exercis
test
could
use
predict
hape
found
subject
poor
cardiac
ventilatori
respons
hypoxia
suscept
hape
assess
sever
paramet
includ
heart
rate
oxygen
satur
ratio
minut
ventil
oxygen
satur
ratio
establish
mathemat
model
could
predict
hape
establish
discrimin
model
base
z
b
x
b
x
coeffici
b
b
z
discrimin
threshold
model
z
z
defin
nonam
z
z
defin
am
discrimin
model
high
sensit
high
accuraci
predict
hape
endocrin
paramet
may
also
use
predict
hape
exampl
cai
yang
use
radioimmunoassay
measur
blood
level
endocrin
paramet
includ
thyroid
stimul
hormon
adrenocorticotrop
hormon
corticotropin
hormon
found
plasma
cortisol
urin
corticosteroid
level
could
predict
hape
accuraci
luo
et
al
compar
sequenc
mitochondri
genom
hape
patient
rat
high
altitud
versu
sequenc
healthi
individu
high
altitud
anim
sea
level
identifi
singlenucleotid
polymorph
nine
gene
mitochondri
dna
affect
gene
encod
protein
control
mitochondri
electron
transport
base
singlenucleotid
polymorph
mitochondri
dna
dna
dna
develop
kit
use
predict
suscept
hape
kit
use
screen
subject
suscept
hape
ascend
high
altitud
anoth
studi
qiu
et
al
compar
genet
paramet
patient
hape
well
peopl
live
tibetan
han
chines
migrant
found
human
leucocyt
antigen
hla
particularli
associ
increas
suscept
hape
thu
specul
suscept
hape
relat
genet
factor
also
influenc
suscept
gene
prevent
hape
well
associ
symptom
sign
import
reduc
incid
among
ascend
high
altitud
achiev
follow
factor
particularli
import
maintain
bodi
warmth
appropri
insul
avoid
upper
respiratori
tract
infect
sever
day
ascend
high
altitud
bath
avoid
reduc
exposur
cold
temperatur
avoid
fatigu
physic
activ
high
altitud
perform
intens
sea
level
durat
activ
h
similarli
bodi
must
given
suffici
time
rest
time
high
altitud
stop
alcohol
intak
fifteen
day
ascend
high
altitud
consumpt
alcohol
stop
emot
stress
unwant
emot
tension
avoid
optim
aggress
maintain
patient
upper
respiratori
tract
infect
care
monitor
time
high
altitud
howev
delay
ascent
infect
fulli
resolv
prefer
oxygen
must
avail
high
altitud
either
maintain
high
oxygen
level
live
quarter
suppli
compress
oxygen
tank
use
physic
activ
food
water
sanit
diet
contain
high
level
carbohydr
protein
low
level
fat
recommend
intak
vitamin
also
increas
use
drug
rhodiola
rosea
zangtianlu
codonopsi
compound
tablet
shenqi
pollen
tablet
acetazolamid
time
high
altitud
also
reduc
risk
hape
peopl
work
high
altitud
construct
worker
prevent
measur
particularli
import
outlin
essenti
provid
suffici
nutrient
rest
insul
cold
well
limit
labor
intens
durat
labor
avoid
fatigu
shiftwork
also
recommend
may
entail
day
work
high
altitud
follow
period
rest
low
altitud
provid
effect
rest
condit
shiftwork
also
reduc
incid
chronic
mountain
sick
induc
long
period
physic
demand
work
high
altitud
also
essenti
ensur
adequ
medic
team
enabl
earli
detect
diagnosi
treatment
mountain
sick
hape
occur
final
individu
plan
ascend
high
altitud
receiv
educ
regard
prevent
treatment
hape
take
appropri
measur
decreas
risk
develop
hape
maintain
posit
attitud
ascend
high
altitud
take
measur
prevent
hape
consid
possibl
treatment
optimist
fear
high
altitud
maintain
bodi
temperatur
avoid
hyperphagia
stop
smoke
alcohol
consumpt
conduct
appropri
excis
avoid
strenuou
exercis
fatigu
worri
troubl
sleep
tri
maintain
good
sleep
qualiti
pay
attent
cough
particularli
cough
event
bloodi
sputum
consid
seek
treatment
consid
bed
rest
oxygen
inhal
awar
headach
vomit
unsteadi
walk
symptom
hape
check
physician
treatment
start
soon
possibl
even
symptom
mild
time
comprehens
treatment
favor
posit
outcom
